Spero Therapeutics Inc (SPRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 12-2015 | |
| Operating Expenses | 0 | 7,914 | 0 |
| Operating Income | N/A | -7,914 | N/A |
| Other Income | 0 | -4 | 0 |
| Pre-tax Income | 0 | -7,918 | 0 |
| Net Income Continuous | N/A | -7,918 | N/A |
| Minority Interests | N/A | -1,602 | N/A |
| Net Income | $N/A | $-6,316 | $N/A |
| EPS Basic Total Ops | N/A | -23.23 | N/A |
| EPS Basic Continuous Ops | N/A | -24.83 | N/A |
| EPS Diluted Total Ops | N/A | -23.23 | N/A |
| EPS Diluted Continuous Ops | N/A | -24.83 | N/A |
| EBITDA(a) | $N/A | $-7,914 | $N/A |